Presented By: Maureen Shogan, MN, RNC
Watch the Neonatal Abstinence Syndrome webinar to hear about exciting, new data which affect neonatal outcomes when using prenatal buprenorphine compared to the more familiar drug, methadone. Successful strategies are shared with the goal to maintain reliability and avoid common pitfalls when using the neonatal abstinence scoring tool.
- Differentiate variations in neonatal withdrawal from prenatal exposure to oxycodone and hydrocodone versus buprenorphine (Subutex®) and methadone.
- Discuss reliable, consistent, and objective nursing assessment of neonatal abstinence syndrome utilizing definitions for scorers.
- Describe variations in pharmacologic interventions for the newborn experiencing withdrawal from opiates.
WHO SHOULD WATCH
Your entire healthcare team will benefit from this session so please be sure to tune in.
For OB inquiries, please contact Heather Gocke at (818) 545-3351 or email@example.com.